Stretch limos were the ultimate status symbol. Now they're going for cheap on Craigslist.
Culturally, limousines have gone from "oooh" to "ick," and they're dying out accordingly. They've fallen out of favor. Maybe ...
Mission Network News10d
The horror of heroin – and what to do about it
International (MNN) – Heroin is a monstrous foe. People caught in its clutches might get a temporary high, but even one use ...
AbbVie Gets CHMP Backing for Elahere in Ovarian Cancer
Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...
Obesity drug developer BioAge seeks up to $587 mln valuation in US IPO
Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...
It's been a decade since 43 students disappeared in Mexico. Their parents still fight for answers
The parents of 43 students of a radical teachers college who disappeared in Mexico are still searching for them 10 years ...
Merck wins first FDA approval for Keytruda as a treatment for mesothelioma
Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a ...
Cocaine arrest in Bozeman raises questions about how often drugs sent via mail
Missouri River Drug Task Force Commander Nathan Kamerman says the task force has seen everything come through the mail, and ...
U.S. drug deaths drop for the first time in years: CDC
For the first time in decades, the U.S. is experiencing a sudden and unprecedented decline in overdose deaths. MSNBC medical ...
Weight loss drug developer BioAge seeks up to $602M valuation in U.S. IPO
Obesity drug developer BioAge Labs (BIOA) files for U.S. IPO to offer 7.5M shares at $17-$19 implying valution of up to $602M ...
Do queasy side effects mean the end of weight-loss drug stock hype?
The bloom may be off the rose for obesity drugs as reports of side effects for high doses of GLP-1 drugs. GLP-1s were ...
Sanofi: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old
Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a phase 3 study showing a significantly greater proportion ...
Ainos, Inc.: Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts
SAN DIEGO, CA / ACCESSWIRE / September 20, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testi ...